TRIAMTERENE

TRIAMTERENE was reported 7326 times

TRIAMTERENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOOT PROSTHESIS USER 5 0.3333
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 19 0.0179
2 REBOUND ACID HYPERSECRETION 54 0.0178
3 CRYSTAL NEPHROPATHY 10 0.0169
4 NEPHROGENIC ANAEMIA 58 0.0125
5 HYPERPARATHYROIDISM SECONDARY 27 0.0108
6 ANAEMIA OF CHRONIC DISEASE 7 0.0077
7 HYPOCHLORAEMIA 9 0.0077
8 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 12 0.0075
9 VERTEBRAL FORAMINAL STENOSIS 6 0.0073
10 DIABETIC NEUROPATHY 33 0.0067
11 CHRONIC KIDNEY DISEASE 479 0.0063
12 PSYCHOLOGICAL TRAUMA 54 0.0063
13 EXCESSIVE GRANULATION TISSUE 5 0.0062
14 HAIR DISORDER 51 0.0062
15 INNER EAR DISORDER 6 0.0056
16 ANOGENITAL WARTS 5 0.0056
17 LEFT ATRIAL DILATATION 7 0.0055
18 END STAGE RENAL DISEASE 96 0.0053
19 LUMBAR RADICULOPATHY 6 0.0052
20 METABOLIC ALKALOSIS 8 0.0050
21 HYPERTENSIVE HEART DISEASE 9 0.0048
22 HAIR TEXTURE ABNORMAL 62 0.0046
23 HAIR COLOUR CHANGES 57 0.0046
24 CARDIOACTIVE DRUG LEVEL INCREASED 6 0.0046
25 MEGACOLON 7 0.0045
26 BENIGN NEOPLASM 5 0.0044
27 SPINAL COLUMN STENOSIS 20 0.0042
28 MADAROSIS 47 0.0040
29 TUBULOINTERSTITIAL NEPHRITIS 69 0.0037
30 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 17 0.0034
31 SPINAL OSTEOARTHRITIS 29 0.0033
32 ESSENTIAL HYPERTENSION 6 0.0033
33 HEART INJURY 8 0.0032
34 VENTRICULAR HYPERTROPHY 8 0.0032
35 ILEUS PARALYTIC 14 0.0031
36 COSTOCHONDRITIS 5 0.0031
37 COLONIC POLYP 5 0.0030
38 INTERVERTEBRAL DISC DEGENERATION 28 0.0030
39 PLANTAR FASCIITIS 10 0.0030
40 FOAMING AT MOUTH 6 0.0030
41 SHOULDER ARTHROPLASTY 8 0.0030
42 HEPATIC CYST 10 0.0029
43 POLYCYTHAEMIA 6 0.0029
44 ELECTRIC SHOCK SENSATION 8 0.0029
45 PHARYNGEAL DISORDER 8 0.0028
46 PERIODONTITIS 6 0.0028
47 HYPERTONIC BLADDER 8 0.0028
48 SCOLIOSIS 17 0.0027
49 LUMBAR SPINAL STENOSIS 8 0.0027
50 RENAL INJURY 81 0.0027
51 AORTIC ARTERIOSCLEROSIS 7 0.0027
52 MULTIPLE INJURIES 17 0.0027
53 THERAPEUTIC AGENT TOXICITY 9 0.0027
54 FEAR OF DEATH 6 0.0027
55 RADICULOPATHY 7 0.0027
56 MITRAL VALVE INCOMPETENCE 30 0.0026
57 ROTATOR CUFF SYNDROME 34 0.0026
58 TRICUSPID VALVE INCOMPETENCE 21 0.0026
59 HYPERLIPIDAEMIA 31 0.0026
60 EARLY SATIETY 5 0.0026
61 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
62 HAEMORRHAGIC ANAEMIA 11 0.0025
63 RADIUS FRACTURE 6 0.0025
64 PNEUMONIA ASPIRATION 62 0.0025
65 RENAL FAILURE 329 0.0025
66 ECONOMIC PROBLEM 37 0.0024
67 BLOOD POTASSIUM DECREASED 73 0.0024
68 HYPERPARATHYROIDISM 5 0.0024
69 GASTROOESOPHAGEAL REFLUX DISEASE 193 0.0024
70 RENAL CYST 19 0.0024
71 NERVE COMPRESSION 22 0.0024
72 BODY HEIGHT DECREASED 25 0.0023
73 CEREBROVASCULAR DISORDER 7 0.0023
74 HIATUS HERNIA 30 0.0023
75 VENTRICULAR DYSFUNCTION 6 0.0023
76 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
77 IMPAIRED QUALITY OF LIFE 33 0.0023
78 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
79 DIABETIC NEPHROPATHY 5 0.0023
80 HAEMORRHOIDAL HAEMORRHAGE 11 0.0023
81 HAEMORRHAGIC DIATHESIS 8 0.0022
82 CANDIDIASIS 9 0.0022
83 NON-CARDIAC CHEST PAIN 7 0.0022
84 OSTEOARTHRITIS 93 0.0022
85 RHINALGIA 6 0.0022
86 JOINT EFFUSION 15 0.0022
87 HYPERKERATOSIS 12 0.0022
88 ATELECTASIS 21 0.0022
89 PERIPHERAL VASCULAR DISORDER 11 0.0021
90 BUNDLE BRANCH BLOCK LEFT 9 0.0021
91 DIVERTICULUM 15 0.0021
92 FIBULA FRACTURE 6 0.0021
93 FOOT DEFORMITY 23 0.0021
94 STRESS CARDIOMYOPATHY 12 0.0021
95 RENAL TUBULAR NECROSIS 20 0.0020
96 ACUTE KIDNEY INJURY 308 0.0020
97 RENAL FAILURE CHRONIC 15 0.0019
98 TIBIA FRACTURE 9 0.0019
99 POLYARTHRITIS 10 0.0019
100 CORONARY ARTERY OCCLUSION 26 0.0019
101 AORTIC VALVE INCOMPETENCE 8 0.0019
102 ANIMAL BITE 5 0.0019
103 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
104 BLOOD SODIUM DECREASED 35 0.0019
105 ANGINA UNSTABLE 12 0.0018
106 CHONDROPATHY 5 0.0018
107 LYMPHOPENIA 26 0.0018
108 TONGUE DISCOLOURATION 8 0.0018
109 JOINT RANGE OF MOTION DECREASED 24 0.0018
110 MENISCUS INJURY 11 0.0018
111 ANAL HAEMORRHAGE 5 0.0018
112 ULCER HAEMORRHAGE 12 0.0018
113 DIABETIC RETINOPATHY 6 0.0018
114 HYPERPHAGIA 7 0.0018
115 DIFFICULTY IN WALKING 6 0.0017
116 BURSITIS 21 0.0017
117 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
118 AORTIC STENOSIS 6 0.0017
119 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7 0.0017
120 TRIGGER FINGER 7 0.0017
121 AORTIC ANEURYSM 13 0.0017
122 ARTERIOSCLEROSIS 16 0.0017
123 MACULOPATHY 6 0.0017
124 FIBRIN D DIMER INCREASED 6 0.0017
125 FOOT FRACTURE 32 0.0017
126 SINUS HEADACHE 10 0.0017
127 CREPITATIONS 5 0.0017
128 MULTIPLE ALLERGIES 13 0.0017
129 HYPERCHOLESTEROLAEMIA 16 0.0017
130 CAROTID ARTERY OCCLUSION 6 0.0016
131 CARPAL TUNNEL SYNDROME 23 0.0016
132 UTERINE LEIOMYOMA 12 0.0016
133 BLINDNESS TRANSIENT 12 0.0016
134 CORONARY ARTERY DISEASE 49 0.0016
135 INFLAMMATORY MARKER INCREASED 8 0.0016
136 CHRONIC SINUSITIS 6 0.0016
137 ABDOMINAL ADHESIONS 5 0.0016
138 RHINITIS ALLERGIC 7 0.0016
139 PARANASAL SINUS HYPERSECRETION 6 0.0016
140 BILE DUCT STONE 5 0.0016
141 CUSHINGOID 5 0.0016
142 IRON DEFICIENCY 7 0.0016
143 HAND FRACTURE 11 0.0016
144 SYNOVIAL CYST 7 0.0015
145 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
146 APPETITE DISORDER 10 0.0015
147 OESOPHAGEAL CANDIDIASIS 6 0.0015
148 CEREBRAL ATROPHY 6 0.0015
149 GOUT 27 0.0015
150 ATRIAL FLUTTER 12 0.0015
151 MUSCLE STRAIN 13 0.0015
152 CARDIAC MURMUR 13 0.0015
153 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
154 CHOLECYSTITIS CHRONIC 10 0.0015
155 COMPRESSION FRACTURE 8 0.0015
156 SKIN TIGHTNESS 7 0.0015
157 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
158 GOITRE 6 0.0015
159 GALLBLADDER DISORDER 26 0.0015
160 SPINAL COMPRESSION FRACTURE 12 0.0014
161 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
162 ANHEDONIA 38 0.0014
163 VITAMIN D DEFICIENCY 14 0.0014
164 BONE DISORDER 26 0.0014
165 EXOSTOSIS 13 0.0014
166 EXPIRED DRUG ADMINISTERED 7 0.0014
167 UTERINE HAEMORRHAGE 6 0.0014
168 INTERVERTEBRAL DISC DISORDER 6 0.0014
169 LUNG NEOPLASM 6 0.0014
170 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
171 FRUSTRATION 5 0.0014
172 PHOTOSENSITIVITY REACTION 23 0.0014
173 CORONARY ARTERY STENOSIS 7 0.0014
174 BLOOD MAGNESIUM DECREASED 12 0.0014
175 FACIAL BONES FRACTURE 5 0.0014
176 OSTEOPENIA 21 0.0014
177 CARDIOMEGALY 17 0.0014
178 INTERVERTEBRAL DISC PROTRUSION 30 0.0014
179 DIVERTICULUM INTESTINAL 6 0.0014
180 HYPERTRIGLYCERIDAEMIA 8 0.0014
181 ANKLE FRACTURE 21 0.0014
182 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
183 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
184 HYPERSOMNIA 38 0.0013
185 JOINT DISLOCATION 14 0.0013
186 COMA 63 0.0013
187 VITREOUS FLOATERS 13 0.0013
188 LOCAL SWELLING 23 0.0013
189 MYOCARDIAL ISCHAEMIA 15 0.0013
190 INGUINAL HERNIA 8 0.0013
191 LIGAMENT SPRAIN 13 0.0013
192 ECCHYMOSIS 9 0.0013
193 INJECTION SITE PAPULE 6 0.0013
194 CLAVICLE FRACTURE 5 0.0013
195 TRANSIENT ISCHAEMIC ATTACK 44 0.0013
196 GINGIVAL DISORDER 5 0.0013
197 LARGE INTESTINE POLYP 9 0.0013
198 BLOOD CHOLESTEROL ABNORMAL 6 0.0013
199 BRUXISM 7 0.0013
200 TENDON RUPTURE 16 0.0013
201 PIGMENTATION DISORDER 8 0.0013
202 VITAMIN D DECREASED 11 0.0013
203 NEPHROPATHY 12 0.0013
204 HAEMORRHOIDS 25 0.0013
205 MUSCULOSKELETAL DISCOMFORT 22 0.0013
206 TYPE 2 DIABETES MELLITUS 43 0.0013
207 VENTRICULAR TACHYCARDIA 21 0.0013
208 TOOTH FRACTURE 14 0.0013
209 DYSPHONIA 74 0.0013
210 ALOPECIA 247 0.0013
211 FAECAL INCONTINENCE 6 0.0012
212 RASH VESICULAR 6 0.0012
213 FINGER DEFORMITY 6 0.0012
214 CONTUSION 119 0.0012
215 DECUBITUS ULCER 10 0.0012
216 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
217 JOINT INJURY 26 0.0012
218 DYSGRAPHIA 8 0.0012
219 TOOTH INFECTION 16 0.0012
220 FOOT OPERATION 6 0.0012
221 ANEURYSM 6 0.0012
222 SLEEP APNOEA SYNDROME 23 0.0012
223 HYPERNATRAEMIA 6 0.0012
224 RENAL FAILURE ACUTE 51 0.0012
225 FUNGAL INFECTION 40 0.0012
226 INCREASED TENDENCY TO BRUISE 11 0.0012
227 HEART RATE IRREGULAR 27 0.0012
228 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
229 ERYSIPELAS 6 0.0012
230 PAROSMIA 9 0.0012
231 SCIATICA 19 0.0012
232 OSTEOPOROSIS 49 0.0012
233 HALLUCINATIONS, MIXED 5 0.0012
234 CATARACT OPERATION 7 0.0012
235 HIP ARTHROPLASTY 18 0.0012
236 DENTAL CARIES 13 0.0012
237 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
238 PERIPHERAL COLDNESS 16 0.0012
239 PAIN IN JAW 33 0.0012
240 MUSCULOSKELETAL PAIN 61 0.0012
241 BRONCHITIS 86 0.0012
242 VARICOSE VEIN 6 0.0012
243 STOMACH DISCOMFORT 6 0.0012
244 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
245 HEPATIC LESION 5 0.0012
246 FAILURE TO THRIVE 6 0.0012
247 HYPOKALAEMIA 53 0.0011
248 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
249 OEDEMA PERIPHERAL 139 0.0011
250 BLOOD ALBUMIN DECREASED 9 0.0011
251 PHARYNGOLARYNGEAL PAIN 6 0.0011
252 PRE-EXISTING CONDITION IMPROVED 7 0.0011
253 OVERWEIGHT 6 0.0011
254 BLADDER DISORDER 11 0.0011
255 MUSCULOSKELETAL CHEST PAIN 17 0.0011
256 TENDONITIS 17 0.0011
257 ORAL DISORDER 8 0.0011
258 ABNORMAL DREAMS 30 0.0011
259 EMBOLISM 9 0.0011
260 CARDIAC FLUTTER 7 0.0011
261 NERVE INJURY 12 0.0011
262 SLUGGISHNESS 11 0.0011
263 FEAR 29 0.0011
264 HEART RATE ABNORMAL 6 0.0011
265 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
266 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 56 0.0011
267 GASTRITIS EROSIVE 5 0.0011
268 LIMB DISCOMFORT 33 0.0011
269 GASTRITIS 28 0.0011
270 LACERATION 10 0.0011
271 PERONEAL NERVE PALSY 6 0.0011
272 MUSCLE TIGHTNESS 17 0.0010
273 ANGINA PECTORIS 30 0.0010
274 SKIN ATROPHY 6 0.0010
275 GLAUCOMA 20 0.0010
276 ATRIAL FIBRILLATION 101 0.0010
277 HUMERUS FRACTURE 5 0.0010
278 SINUS BRADYCARDIA 10 0.0010
279 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
280 RALES 6 0.0010
281 SKIN WARM 6 0.0010
282 EAR PAIN 20 0.0010
283 FIBROMYALGIA 25 0.0010
284 UNDERDOSE 75 0.0010
285 HYPOVOLAEMIA 6 0.0010
286 CARDIAC FAILURE CONGESTIVE 82 0.0010
287 LUNG INFILTRATION 9 0.0010
288 DECREASED INTEREST 6 0.0010
289 MIDDLE INSOMNIA 19 0.0010
290 BACK INJURY 11 0.0010
291 HAIR GROWTH ABNORMAL 7 0.0010
292 NASAL DISCOMFORT 8 0.0010
293 HAEMATOCRIT DECREASED 20 0.0010
294 BALANCE DISORDER 87 0.0010
295 MYOCLONUS 12 0.0010
296 ODYNOPHAGIA 6 0.0010
297 APHONIA 14 0.0010
298 NECK PAIN 56 0.0010
299 WRIST FRACTURE 12 0.0010
300 BLOOD DISORDER 8 0.0010
301 DYSPEPSIA 98 0.0010
302 BLOOD COUNT ABNORMAL 15 0.0010
303 BLOOD CHOLESTEROL INCREASED 46 0.0010
304 DRY MOUTH 80 0.0010
305 DYSLIPIDAEMIA 5 0.0010
306 DRY THROAT 10 0.0010
307 ORAL PAIN 22 0.0010
308 TOOTH ABSCESS 10 0.0010
309 HEAD INJURY 31 0.0010
310 ARTHRITIS 77 0.0010
311 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
312 HYPONATRAEMIA 55 0.0010
313 POOR QUALITY SLEEP 21 0.0010
314 FEMORAL NECK FRACTURE 5 0.0010
315 CEREBRAL ISCHAEMIA 5 0.0010
316 VISUAL FIELD DEFECT 7 0.0010
317 BASAL CELL CARCINOMA 15 0.0010
318 POLLAKIURIA 40 0.0010
319 SQUAMOUS CELL CARCINOMA 9 0.0010
320 INCONTINENCE 10 0.0009
321 PRESYNCOPE 23 0.0009
322 TOOTHACHE 17 0.0009
323 OSTEOMYELITIS 17 0.0009
324 RETCHING 20 0.0009
325 RESTLESS LEGS SYNDROME 17 0.0009
326 ANOREXIA 12 0.0009
327 ERUCTATION 18 0.0009
328 GINGIVITIS 5 0.0009
329 INCOHERENT 6 0.0009
330 POOR QUALITY DRUG ADMINISTERED 6 0.0009
331 CHEILITIS 5 0.0009
332 HYSTERECTOMY 8 0.0009
333 BACK PAIN 213 0.0009
334 CHOLELITHIASIS 30 0.0009
335 BOWEL MOVEMENT IRREGULARITY 7 0.0009
336 BLOOD CALCIUM INCREASED 8 0.0009
337 INJURY 64 0.0009
338 STAPHYLOCOCCAL INFECTION 30 0.0009
339 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
340 THYROID DISORDER 14 0.0009
341 KNEE ARTHROPLASTY 19 0.0009
342 SKIN MASS 6 0.0009
343 BLOOD UREA INCREASED 15 0.0009
344 FLUSHING 91 0.0009
345 MUSCLE SPASMS 164 0.0009
346 FULL BLOOD COUNT DECREASED 18 0.0009
347 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
348 NEPHROPATHY TOXIC 10 0.0009
349 BLOOD CALCIUM DECREASED 10 0.0009
350 DYSGEUSIA 66 0.0009
351 POSTOPERATIVE WOUND INFECTION 6 0.0009
352 TOOTH EXTRACTION 11 0.0009
353 AGEUSIA 22 0.0009
354 ABNORMAL LOSS OF WEIGHT 6 0.0009
355 RENAL DISORDER 41 0.0009
356 GENERALISED ERYTHEMA 5 0.0009
357 SCAB 10 0.0009
358 INTERNAL HAEMORRHAGE 10 0.0009
359 RIB FRACTURE 18 0.0009
360 GASTROINTESTINAL HAEMORRHAGE 73 0.0009
361 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
362 JOINT SWELLING 105 0.0009
363 CORONARY ARTERY BYPASS 5 0.0009
364 DYSURIA 32 0.0009
365 EPISTAXIS 65 0.0009
366 RHINITIS 7 0.0009
367 DIABETES MELLITUS 66 0.0009
368 FLATULENCE 49 0.0009
369 ARTHROPATHY 48 0.0009
370 HYPERVENTILATION 5 0.0009
371 PAIN IN EXTREMITY 254 0.0009
372 BREAST CANCER FEMALE 23 0.0009
373 BACK DISORDER 14 0.0009
374 HEPATIC STEATOSIS 16 0.0009
375 PERIPHERAL SWELLING 132 0.0009
376 MOUTH ULCERATION 18 0.0009
377 FLANK PAIN 8 0.0009
378 INCORRECT DRUG ADMINISTRATION DURATION 24 0.0009
379 GLOSSODYNIA 19 0.0008
380 ACUTE MYOCARDIAL INFARCTION 25 0.0008
381 SINUS TACHYCARDIA 12 0.0008
382 BLOOD URINE PRESENT 16 0.0008
383 COAGULOPATHY 14 0.0008
384 CARDIAC PACEMAKER INSERTION 5 0.0008
385 SOMNOLENCE 168 0.0008
386 DEPRESSION 189 0.0008
387 MENTAL STATUS CHANGES 23 0.0008
388 HERNIA 16 0.0008
389 WRONG TECHNIQUE IN DRUG USAGE PROCESS 30 0.0008
390 BLOOD PRESSURE INCREASED 126 0.0008
391 NOCTURIA 10 0.0008
392 INSOMNIA 218 0.0008
393 INJECTION SITE NODULE 9 0.0008
394 ULCER 13 0.0008
395 PSEUDOMONAS INFECTION 7 0.0008
396 PULMONARY HYPERTENSION 17 0.0008
397 OBESITY 13 0.0008
398 CARDIOMYOPATHY 12 0.0008
399 GENERALISED OEDEMA 10 0.0008
400 FEELING DRUNK 6 0.0008
401 HYPERTENSION 171 0.0008
402 GINGIVAL BLEEDING 11 0.0008
403 ANXIETY 229 0.0008
404 BONE PAIN 47 0.0008
405 OCULAR DISCOMFORT 9 0.0008
406 DYSPNOEA EXERTIONAL 30 0.0008
407 HYPOAESTHESIA 119 0.0008
408 OEDEMA 43 0.0008
409 HYPOCALCAEMIA 15 0.0008
410 IMPAIRED DRIVING ABILITY 9 0.0008
411 MULTIPLE FRACTURES 13 0.0008
412 HYPOMAGNESAEMIA 11 0.0008
413 ROAD TRAFFIC ACCIDENT 33 0.0008
414 MICTURITION URGENCY 9 0.0008
415 EMOTIONAL DISTRESS 95 0.0008
416 FACIAL PAIN 7 0.0008
417 CONSTIPATION 171 0.0008
418 TINNITUS 36 0.0008
419 LIPASE INCREASED 6 0.0008
420 NEOPLASM 9 0.0008
421 BLOOD TEST ABNORMAL 11 0.0008
422 GASTRIC HAEMORRHAGE 9 0.0008
423 LIP SWELLING 26 0.0008
424 SINUSITIS 80 0.0008
425 FALL 259 0.0008
426 SEASONAL ALLERGY 11 0.0008
427 URINARY INCONTINENCE 23 0.0008
428 NIGHT SWEATS 25 0.0008
429 CELLULITIS 39 0.0008
430 RHINORRHOEA 50 0.0008
431 VISION BLURRED 106 0.0008
432 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
433 APPLICATION SITE VESICLES 5 0.0008
434 VENTRICULAR EXTRASYSTOLES 8 0.0008
435 RED BLOOD CELL COUNT DECREASED 22 0.0008
436 DEEP VEIN THROMBOSIS 50 0.0008
437 ORAL HERPES 15 0.0008
438 HAEMORRHAGIC STROKE 6 0.0008
439 RECTAL HAEMORRHAGE 33 0.0008
440 HEMIPARESIS 13 0.0008
441 NODULE 10 0.0008
442 DEHYDRATION 102 0.0008
443 FEELING ABNORMAL 183 0.0008
444 JOINT STIFFNESS 20 0.0008
445 IMPAIRED HEALING 25 0.0008
446 SCAR 13 0.0008
447 BLOOD IRON DECREASED 9 0.0008
448 IRON DEFICIENCY ANAEMIA 7 0.0008
449 GRAND MAL CONVULSION 7 0.0008
450 SNEEZING 17 0.0008
451 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
452 FURUNCLE 6 0.0008
453 LIVER FUNCTION TEST ABNORMAL 22 0.0008
454 FLUID OVERLOAD 11 0.0008
455 ARTHRALGIA 314 0.0008
456 MACULAR DEGENERATION 9 0.0008
457 DYSSTASIA 22 0.0008
458 GAIT DISTURBANCE 144 0.0008
459 DIARRHOEA HAEMORRHAGIC 7 0.0007
460 MOVEMENT DISORDER 24 0.0007
461 HEART RATE INCREASED 74 0.0007
462 IRRITABLE BOWEL SYNDROME 16 0.0007
463 LABORATORY TEST ABNORMAL 22 0.0007
464 ABDOMINAL PAIN UPPER 153 0.0007
465 HOT FLUSH 56 0.0007
466 SKIN HAEMORRHAGE 11 0.0007
467 STOMATITIS 45 0.0007
468 DECREASED ACTIVITY 8 0.0007
469 MUSCLE DISORDER 6 0.0007
470 SINUS CONGESTION 10 0.0007
471 METASTASES TO LIVER 13 0.0007
472 PULMONARY MASS 11 0.0007
473 FAECES DISCOLOURED 16 0.0007
474 POST PROCEDURAL INFECTION 6 0.0007
475 GASTRIC ULCER 14 0.0007
476 SWOLLEN TONGUE 23 0.0007
477 LIMB INJURY 20 0.0007
478 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
479 POLYURIA 6 0.0007
480 OESOPHAGITIS 8 0.0007
481 PHARMACEUTICAL PRODUCT COMPLAINT 19 0.0007
482 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
483 MUSCULAR WEAKNESS 83 0.0007
484 LETHARGY 42 0.0007
485 CROHN'S DISEASE 5 0.0007
486 BURNING SENSATION 51 0.0007
487 HAEMATOCHEZIA 40 0.0007
488 ACUTE CORONARY SYNDROME 6 0.0007
489 WEIGHT INCREASED 162 0.0007
490 VENTRICULAR FIBRILLATION 8 0.0007
491 HYPOTHYROIDISM 23 0.0007
492 CEREBROVASCULAR ACCIDENT 122 0.0007
493 SKIN DISORDER 24 0.0007
494 SECRETION DISCHARGE 9 0.0007
495 CHOKING 14 0.0007
496 PAIN 439 0.0007
497 RENAL IMPAIRMENT 60 0.0007
498 THROAT IRRITATION 32 0.0007
499 BLISTER 40 0.0007
500 MYALGIA 121 0.0007
501 MUSCLE ATROPHY 9 0.0007
502 FEMUR FRACTURE 22 0.0007
503 EYE INFECTION 8 0.0007
504 SINUS DISORDER 14 0.0007
505 EATING DISORDER 15 0.0007
506 PSORIASIS 92 0.0007
507 NEUROPATHY PERIPHERAL 67 0.0007
508 OROPHARYNGEAL PAIN 65 0.0007
509 OVARIAN CYST 7 0.0007
510 CYANOSIS 11 0.0007
511 NEURALGIA 17 0.0007
512 SPINAL FRACTURE 14 0.0007
513 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
514 SKIN ULCER 18 0.0007
515 LACRIMATION INCREASED 21 0.0007
516 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
517 ASTHENIA 261 0.0007
518 EMPHYSEMA 7 0.0007
519 PULMONARY OEDEMA 31 0.0007
520 DIZZINESS 345 0.0007
521 PALPITATIONS 81 0.0007
522 WEIGHT DECREASED 193 0.0007
523 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
524 CYSTITIS 22 0.0007
525 BLOOD CREATININE INCREASED 45 0.0007
526 ORTHOSTATIC HYPOTENSION 12 0.0007
527 VERTIGO 42 0.0007
528 DRUG EFFECT INCOMPLETE 25 0.0007
529 ABASIA 17 0.0007
530 OSTEONECROSIS OF JAW 17 0.0007
531 RASH MACULAR 24 0.0007
532 BODY TEMPERATURE INCREASED 14 0.0007
533 DIVERTICULITIS 19 0.0007
534 PULMONARY EMBOLISM 65 0.0007
535 ORAL CANDIDIASIS 9 0.0007
536 PULMONARY CONGESTION 9 0.0007
537 FEELING JITTERY 13 0.0007
538 EAR DISCOMFORT 7 0.0007
539 HAEMOPTYSIS 19 0.0007
540 INCREASED APPETITE 13 0.0007
541 URINARY TRACT INFECTION 116 0.0007
542 TEMPERATURE INTOLERANCE 7 0.0007
543 COUGH 190 0.0007
544 LOWER LIMB FRACTURE 13 0.0007
545 ANAEMIA 129 0.0007
546 INTENTIONAL PRODUCT MISUSE 59 0.0007
547 ABDOMINAL DISCOMFORT 113 0.0007
548 EYE SWELLING 25 0.0007
549 TENDERNESS 7 0.0007
550 FLUID RETENTION 34 0.0007
551 PSORIATIC ARTHROPATHY 27 0.0007
552 GASTROENTERITIS VIRAL 12 0.0007
553 HYPOAESTHESIA ORAL 10 0.0007
554 APHASIA 20 0.0007
555 DEPRESSED MOOD 35 0.0007
556 EXPIRED PRODUCT ADMINISTERED 22 0.0007
557 DRY EYE 33 0.0007
558 CRYING 24 0.0007
559 RENAL PAIN 7 0.0007
560 MENTAL IMPAIRMENT 16 0.0007
561 MYOCARDIAL INFARCTION 115 0.0007
562 BLOOD PRESSURE ABNORMAL 13 0.0007
563 HIP FRACTURE 21 0.0007
564 RETINAL DETACHMENT 6 0.0007
565 UPPER LIMB FRACTURE 13 0.0007
566 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
567 ENCEPHALOPATHY 16 0.0007
568 SKIN CANCER 14 0.0006
569 DEAFNESS 17 0.0006
570 PHARYNGEAL OEDEMA 10 0.0006
571 DRUG EFFECT DECREASED 35 0.0006
572 SYNCOPE 65 0.0006
573 INJECTION SITE EXTRAVASATION 8 0.0006
574 ORAL DISCOMFORT 9 0.0006
575 PRURITUS GENERALISED 14 0.0006
576 PERSONALITY CHANGE 6 0.0006
577 PHARYNGITIS 8 0.0006
578 THINKING ABNORMAL 12 0.0006
579 HAEMATURIA 22 0.0006
580 ABDOMINAL DISTENSION 67 0.0006
581 TASTE DISORDER 13 0.0006
582 HEPATIC CIRRHOSIS 12 0.0006
583 EYE PAIN 36 0.0006
584 HYPERHIDROSIS 82 0.0006
585 MULTI-ORGAN FAILURE 11 0.0006
586 GASTROINTESTINAL PAIN 7 0.0006
587 FEELING HOT 39 0.0006
588 UNEVALUABLE EVENT 48 0.0006
589 SPINAL DISORDER 6 0.0006
590 PNEUMOTHORAX 10 0.0006
591 MUSCULOSKELETAL DISORDER 12 0.0006
592 PRURITUS 242 0.0006
593 NASAL CONGESTION 37 0.0006
594 TOOTH DISORDER 14 0.0006
595 RESPIRATORY TRACT CONGESTION 10 0.0006
596 DECREASED APPETITE 146 0.0006
597 INJECTION SITE IRRITATION 8 0.0006
598 THROAT TIGHTNESS 17 0.0006
599 MUSCULOSKELETAL STIFFNESS 55 0.0006
600 DIARRHOEA 405 0.0006
601 HYPERKALAEMIA 22 0.0006
602 EYE IRRITATION 36 0.0006
603 PLEURAL EFFUSION 38 0.0006
604 SKIN INFECTION 7 0.0006
605 VAGINAL HAEMORRHAGE 27 0.0006
606 DYSPHAGIA 59 0.0006
607 HEAD DISCOMFORT 11 0.0006
608 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
609 LOCALISED INFECTION 15 0.0006
610 SKIN LESION 17 0.0006
611 HAEMATOMA 16 0.0006
612 RHEUMATOID ARTHRITIS 70 0.0006
613 THIRST 11 0.0006
614 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
615 CHEST DISCOMFORT 63 0.0006
616 DYSPNOEA 348 0.0006
617 SKIN FISSURES 12 0.0006
618 PHARYNGEAL SWELLING 6 0.0006
619 CHOLECYSTECTOMY 7 0.0006
620 FATIGUE 476 0.0006
621 PARAESTHESIA 96 0.0006
622 CHEST PAIN 113 0.0006
623 SKIN DISCOLOURATION 28 0.0006
624 HYPERAESTHESIA 5 0.0006
625 ESCHERICHIA INFECTION 5 0.0006
626 NASOPHARYNGITIS 112 0.0006
627 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 43 0.0006
628 DRUG DOSE OMISSION 99 0.0006
629 HYPOGLYCAEMIA 29 0.0006
630 SPLENOMEGALY 7 0.0006
631 MALIGNANT MELANOMA 8 0.0006
632 QUALITY OF LIFE DECREASED 8 0.0006
633 HAEMOGLOBIN DECREASED 61 0.0006
634 NERVOUSNESS 31 0.0006
635 LYMPHADENOPATHY 21 0.0006
636 MELAENA 13 0.0006
637 CHILLS 69 0.0006
638 IMPAIRED GASTRIC EMPTYING 8 0.0006
639 DRUG ADMINISTRATION ERROR 18 0.0006
640 EUPHORIC MOOD 6 0.0006
641 THROMBOSIS 47 0.0006
642 EMOTIONAL DISORDER 18 0.0006
643 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
644 DISORIENTATION 23 0.0006
645 EJECTION FRACTION DECREASED 9 0.0006
646 HYPERGLYCAEMIA 21 0.0006
647 HERPES ZOSTER 33 0.0006
648 RESTLESSNESS 21 0.0006
649 COORDINATION ABNORMAL 8 0.0006
650 MASS 8 0.0006
651 RASH PRURITIC 31 0.0006
652 ACUTE RESPIRATORY FAILURE 11 0.0006
653 CATARACT 34 0.0006
654 GROIN PAIN 5 0.0006
655 AMNESIA 37 0.0006
656 GRIP STRENGTH DECREASED 5 0.0006
657 SUDDEN DEATH 6 0.0006
658 HYPERCALCAEMIA 7 0.0006
659 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
660 BRADYCARDIA 30 0.0006
661 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
662 HEPATIC FAILURE 17 0.0006
663 BREAST PAIN 6 0.0006
664 LOSS OF CONSCIOUSNESS 72 0.0006
665 DRY SKIN 75 0.0006
666 TREMOR 93 0.0006
667 ANAL INCONTINENCE 5 0.0006
668 PARAESTHESIA ORAL 8 0.0006
669 PHARYNGITIS STREPTOCOCCAL 6 0.0006
670 ANOSMIA 8 0.0006
671 LEUKOCYTOSIS 10 0.0006
672 NIGHTMARE 19 0.0005
673 METASTASES TO BONE 9 0.0005
674 ASPIRATION 6 0.0005
675 PRODUCT PHYSICAL ISSUE 11 0.0005
676 SKIN BURNING SENSATION 39 0.0005
677 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
678 INFLAMMATION 28 0.0005
679 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
680 BLOOD PRESSURE DECREASED 36 0.0005
681 HEART RATE DECREASED 19 0.0005
682 HYPERTENSIVE CRISIS 6 0.0005
683 MEMORY IMPAIRMENT 74 0.0005
684 CONFUSIONAL STATE 87 0.0005
685 WOUND 15 0.0005
686 MALNUTRITION 6 0.0005
687 DEFORMITY 5 0.0005
688 INTESTINAL PERFORATION 6 0.0005
689 CANDIDA INFECTION 9 0.0005
690 BONE LOSS 8 0.0005
691 TARDIVE DYSKINESIA 15 0.0005
692 NAUSEA 420 0.0005
693 TOOTH LOSS 11 0.0005
694 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
695 DERMATITIS CONTACT 6 0.0005
696 PROTEINURIA 10 0.0005
697 PNEUMONIA 170 0.0005
698 CARDIAC DISORDER 49 0.0005
699 INJECTION SITE PRURITUS 35 0.0005
700 HEADACHE 327 0.0005
701 INJECTION SITE RASH 16 0.0005
702 METASTASES TO LUNG 6 0.0005
703 DELIRIUM 18 0.0005
704 PRODUCT TASTE ABNORMAL 7 0.0005
705 UVEITIS 7 0.0005
706 DIZZINESS POSTURAL 5 0.0005
707 PRODUCT QUALITY ISSUE 70 0.0005
708 MOBILITY DECREASED 37 0.0005
709 ABDOMINAL PAIN 119 0.0005
710 HEPATOMEGALY 5 0.0005
711 WHEEZING 30 0.0005
712 PRODUCT PRESCRIBING ISSUE 11 0.0005
713 CHOLECYSTITIS 6 0.0005
714 INABILITY TO AFFORD MEDICATION 5 0.0005
715 FEELING COLD 14 0.0005
716 HUNGER 7 0.0005
717 SWELLING 47 0.0005
718 RASH GENERALISED 13 0.0005
719 RESPIRATORY DISORDER 15 0.0005
720 INJECTION SITE BRUISING 40 0.0005
721 PRESCRIBED UNDERDOSE 10 0.0005
722 BRAIN INJURY 5 0.0005
723 RASH 217 0.0005
724 HEPATITIS C 6 0.0005
725 SPEECH DISORDER 26 0.0005
726 VISUAL IMPAIRMENT 61 0.0005
727 SWELLING FACE 32 0.0005
728 CONVULSION 28 0.0005
729 SUBDURAL HAEMATOMA 7 0.0005
730 INJECTION SITE HAEMORRHAGE 39 0.0005
731 HAEMORRHAGE 51 0.0005
732 HYPOACUSIS 21 0.0005
733 INJECTION SITE MASS 18 0.0005
734 ASTHMA 55 0.0005
735 SKIN EXFOLIATION 41 0.0005
736 ARRHYTHMIA 23 0.0005
737 DEVICE MALFUNCTION 34 0.0005
738 DISEASE RECURRENCE 23 0.0005
739 BACTERIAL INFECTION 9 0.0005
740 HYPOKINESIA 7 0.0005
741 DISTURBANCE IN ATTENTION 26 0.0005
742 FREQUENT BOWEL MOVEMENTS 13 0.0005
743 EYE DISCHARGE 5 0.0005
744 COMPLETED SUICIDE 40 0.0005
745 NEPHROLITHIASIS 22 0.0005
746 INJECTION SITE PAIN 147 0.0005
747 DRUG-INDUCED LIVER INJURY 15 0.0005
748 DERMATITIS 10 0.0005
749 PERICARDIAL EFFUSION 11 0.0005
750 ABDOMINAL PAIN LOWER 12 0.0005
751 MALAISE 208 0.0005
752 INFLUENZA LIKE ILLNESS 39 0.0005
753 ANGER 16 0.0005
754 DRUG INTERACTION 75 0.0005
755 INTRAOCULAR PRESSURE INCREASED 6 0.0005
756 PULMONARY FIBROSIS 9 0.0005
757 GASTROINTESTINAL DISORDER 42 0.0005
758 HAEMORRHAGE INTRACRANIAL 7 0.0005
759 DYSKINESIA 19 0.0005
760 GASTRIC DISORDER 16 0.0005
761 IRRITABILITY 28 0.0005
762 SURGERY 27 0.0005
763 KIDNEY INFECTION 9 0.0005
764 SEPSIS 51 0.0005
765 TREATMENT NONCOMPLIANCE 25 0.0005
766 INCORRECT PRODUCT STORAGE 6 0.0005
767 EYE DISORDER 15 0.0005
768 INTENTIONAL DOSE OMISSION 13 0.0005
769 DISABILITY 9 0.0005
770 CARDIO-RESPIRATORY ARREST 19 0.0005
771 PANCREATITIS 24 0.0005
772 APPLICATION SITE PAIN 10 0.0005
773 VOMITING 213 0.0005
774 WHITE BLOOD CELL COUNT DECREASED 49 0.0005
775 PRODUCT SUBSTITUTION ISSUE 26 0.0005
776 VISUAL ACUITY REDUCED 15 0.0005
777 DELUSION 7 0.0005
778 COLITIS 17 0.0004
779 CARDIAC ARREST 37 0.0004
780 JAUNDICE 12 0.0004
781 PRODUCT DOSE OMISSION 29 0.0004
782 APPLICATION SITE PRURITUS 10 0.0004
783 HEPATIC ENZYME INCREASED 30 0.0004
784 PRODUCTIVE COUGH 21 0.0004
785 ABSCESS 7 0.0004
786 HALLUCINATION 33 0.0004
787 METABOLIC ACIDOSIS 14 0.0004
788 APPLICATION SITE RASH 6 0.0004
789 ADVERSE EVENT 40 0.0004
790 MUSCLE TWITCHING 10 0.0004
791 BLOOD POTASSIUM INCREASED 7 0.0004
792 INTENTIONAL DRUG MISUSE 9 0.0004
793 ELECTROLYTE IMBALANCE 5 0.0004
794 HYPOPHAGIA 11 0.0004
795 ERECTILE DYSFUNCTION 11 0.0004
796 UNRESPONSIVE TO STIMULI 11 0.0004
797 BLINDNESS UNILATERAL 6 0.0004
798 PHOTOPHOBIA 8 0.0004
799 DYSARTHRIA 16 0.0004
800 COVID-19 PNEUMONIA 5 0.0004
801 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
802 PLATELET COUNT DECREASED 45 0.0004
803 INFLUENZA 47 0.0004
804 BACTERAEMIA 5 0.0004
805 IMPAIRED WORK ABILITY 9 0.0004
806 URINARY RETENTION 14 0.0004
807 MULTIPLE SCLEROSIS 20 0.0004
808 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
809 POST PROCEDURAL COMPLICATION 8 0.0004
810 BONE DENSITY DECREASED 13 0.0004
811 HYPOTENSION 83 0.0004
812 EAR INFECTION 11 0.0004
813 GASTROENTERITIS 6 0.0004
814 CIRCULATORY COLLAPSE 7 0.0004
815 SLEEP DISORDER 29 0.0004
816 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 74 0.0004
817 CEREBRAL INFARCTION 10 0.0004
818 ERYTHEMA 84 0.0004
819 PAIN OF SKIN 11 0.0004
820 ANGIOEDEMA 18 0.0004
821 PARANOIA 7 0.0004
822 INJECTION SITE ERYTHEMA 50 0.0004
823 INCORRECT DOSE ADMINISTERED 92 0.0004
824 CYST 5 0.0004
825 PRODUCT USE IN UNAPPROVED INDICATION 99 0.0004
826 CHROMATURIA 9 0.0004
827 COLD SWEAT 7 0.0004
828 PROCEDURAL PAIN 11 0.0004
829 BLOOD GLUCOSE DECREASED 19 0.0004
830 AGITATION 29 0.0004
831 TACHYCARDIA 35 0.0004
832 THROMBOCYTOPENIA 44 0.0004
833 DRUG DISPENSING ERROR 6 0.0004
834 ISCHAEMIC STROKE 7 0.0004
835 VIRAL INFECTION 13 0.0004
836 THERAPY CESSATION 20 0.0004
837 GAIT INABILITY 13 0.0004
838 INJECTION SITE WARMTH 8 0.0004
839 PRODUCT USE ISSUE 73 0.0004
840 LYMPHOMA 6 0.0004
841 LUNG DISORDER 19 0.0004
842 INJECTION SITE INDURATION 5 0.0004
843 PELVIC PAIN 7 0.0004
844 DIPLOPIA 10 0.0004
845 DRUG INTOLERANCE 37 0.0004
846 HAND DEFORMITY 5 0.0004
847 OCULAR HYPERAEMIA 18 0.0004
848 BLOOD GLUCOSE ABNORMAL 7 0.0004
849 MIGRAINE 36 0.0004
850 URTICARIA 63 0.0004
851 EYE HAEMORRHAGE 5 0.0004
852 INTESTINAL OBSTRUCTION 14 0.0004
853 RESPIRATORY FAILURE 27 0.0004
854 BLOOD BILIRUBIN INCREASED 10 0.0004
855 DEVICE ISSUE 33 0.0004
856 MENTAL DISORDER 16 0.0004
857 HYPERSENSITIVITY 68 0.0004
858 BLOOD GLUCOSE INCREASED 68 0.0004
859 LEUKOPENIA 18 0.0004
860 ILLNESS 37 0.0004
861 COVID-19 63 0.0004
862 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
863 DEMENTIA 10 0.0004
864 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
865 EYE PRURITUS 12 0.0004
866 RASH PAPULAR 8 0.0004
867 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
868 PANCREATITIS ACUTE 8 0.0004
869 HAEMATEMESIS 9 0.0004
870 RESPIRATORY TRACT INFECTION 9 0.0003
871 FEEDING DISORDER 7 0.0003
872 INJECTION SITE HAEMATOMA 5 0.0003
873 DISCOMFORT 21 0.0003
874 MUCOSAL INFLAMMATION 9 0.0003
875 DRUG INEFFECTIVE 453 0.0003
876 NEEDLE ISSUE 10 0.0003
877 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
878 APATHY 5 0.0003
879 ASCITES 10 0.0003
880 DRUG ERUPTION 6 0.0003
881 INFECTION 49 0.0003
882 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
883 COLON CANCER 5 0.0003
884 CONDITION AGGRAVATED 102 0.0003
885 CEREBRAL HAEMORRHAGE 12 0.0003
886 BLOOD PRESSURE FLUCTUATION 8 0.0003
887 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
888 HALLUCINATION, VISUAL 7 0.0003
889 DRUG WITHDRAWAL SYNDROME 29 0.0003
890 DEVICE FAILURE 5 0.0003
891 INSURANCE ISSUE 5 0.0003
892 DEVICE RELATED INFECTION 5 0.0003
893 PANCYTOPENIA 18 0.0003
894 ACUTE MYELOID LEUKAEMIA 5 0.0003
895 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
896 NERVOUS SYSTEM DISORDER 10 0.0003
897 BLINDNESS 13 0.0003
898 SUICIDAL IDEATION 29 0.0003
899 NEOPLASM PROGRESSION 11 0.0003
900 LIVER DISORDER 14 0.0003
901 CARDIOVASCULAR DISORDER 8 0.0003
902 RASH ERYTHEMATOUS 15 0.0003
903 HYPOXIA 11 0.0003
904 PANCREATIC CARCINOMA 9 0.0003
905 CARDIAC FAILURE 25 0.0003
906 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
907 OFF LABEL USE 270 0.0003
908 ECZEMA 16 0.0003
909 APPLICATION SITE ERYTHEMA 8 0.0003
910 OSTEONECROSIS 10 0.0003
911 PRODUCT DOSE OMISSION ISSUE 89 0.0003
912 PANIC ATTACK 11 0.0003
913 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
914 BREAST CANCER 28 0.0003
915 PYREXIA 103 0.0003
916 MOOD ALTERED 8 0.0003
917 MULTIPLE SCLEROSIS RELAPSE 20 0.0003
918 COLITIS ULCERATIVE 13 0.0003
919 ADVERSE DRUG REACTION 26 0.0003
920 DEVICE DEFECTIVE 5 0.0003
921 OXYGEN SATURATION DECREASED 16 0.0003
922 EXTRAPYRAMIDAL DISORDER 7 0.0003
923 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
924 ILL-DEFINED DISORDER 17 0.0003
925 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
926 GENERAL PHYSICAL HEALTH DETERIORATION 32 0.0003
927 INJECTION SITE REACTION 19 0.0003
928 SEPTIC SHOCK 12 0.0003
929 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
930 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
931 PSYCHOTIC DISORDER 8 0.0003
932 TRANSAMINASES INCREASED 6 0.0003
933 CONJUNCTIVITIS 5 0.0003
934 THERAPEUTIC RESPONSE DECREASED 16 0.0003
935 PRODUCT AVAILABILITY ISSUE 6 0.0003
936 WITHDRAWAL SYNDROME 11 0.0003
937 INJECTION SITE SWELLING 20 0.0003
938 SHOCK 6 0.0003
939 PALLOR 7 0.0003
940 RESPIRATORY DISTRESS 7 0.0003
941 MEDICATION ERROR 14 0.0003
942 NEOPLASM MALIGNANT 16 0.0002
943 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
944 PLASMA CELL MYELOMA 9 0.0002
945 DISEASE PROGRESSION 27 0.0002
946 THERAPY INTERRUPTED 16 0.0002
947 C-REACTIVE PROTEIN INCREASED 8 0.0002
948 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
949 TOXICITY TO VARIOUS AGENTS 36 0.0002
950 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
951 FEBRILE NEUTROPENIA 14 0.0002
952 NEUTROPENIA 28 0.0002
953 INJECTION SITE URTICARIA 5 0.0002
954 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
955 THERAPY NON-RESPONDER 9 0.0002
956 ANAPHYLACTIC REACTION 11 0.0002
957 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
958 ACNE 15 0.0002
959 EXTRA DOSE ADMINISTERED 8 0.0002
960 NEUTROPHIL COUNT DECREASED 8 0.0002
961 PRODUCT ADHESION ISSUE 7 0.0002
962 HEPATITIS 5 0.0002
963 LUNG NEOPLASM MALIGNANT 8 0.0002
964 ACCIDENTAL OVERDOSE 7 0.0002
965 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
966 MOOD SWINGS 6 0.0002
967 SEIZURE 21 0.0002
968 INFUSION RELATED REACTION 12 0.0002
969 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
970 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
971 DEATH 150 0.0002
972 COGNITIVE DISORDER 8 0.0002
973 RHABDOMYOLYSIS 7 0.0002
974 NO ADVERSE EVENT 30 0.0002
975 PROSTATE CANCER 13 0.0002
976 DEVICE LEAKAGE 7 0.0002
977 DEVICE DISLOCATION 7 0.0002
978 AGGRESSION 8 0.0002
979 ABNORMAL BEHAVIOUR 6 0.0002
980 DEVICE BREAKAGE 6 0.0001
981 RENAL CANCER 7 0.0001
982 HOSPITALISATION 22 0.0001
983 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
984 OVERDOSE 29 0.0001
985 DERMATITIS ATOPIC 7 0.0001
986 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
987 SUICIDE ATTEMPT 7 0.0001
988 INTERSTITIAL LUNG DISEASE 5 0.0001
989 TREATMENT FAILURE 7 0.0001
990 PRODUCT STORAGE ERROR 7 0.0001
991 DEVICE EXPULSION 5 0.0001
992 DRUG DOSE OMISSION BY DEVICE 5 0.0001
993 DRUG DEPENDENCE 9 0.0001